Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-007108

Options or other derivatives

  • Director acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Quart Barry D Director 2022-06-29 Grant or award · Share Option +30,000 30,000 D
Quart Barry D Director 2022-06-29 Grant or award · Restricted Share Units +5,000 5,000 D
Loading xslF345X03/form4-06302022_010649.xml…